Phototriggered Release of Tumor-Imaging and Therapy Agents from Lyophilized Multifunctional Polyacrylamide Nanoparticles
- 14 November 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 2 (12) , 5663-5675
Abstract
The success of polyacrylamide nanoparticles in drug delivery spurred the creation of variations in surface functional groups. We report herein, a simple, reproducible and an efficient approach for the creation of modifiable nanoparticles that are characterized by their long-term stability and high loading efficiency. In our experiments, hydrophobic photosensitizer, such as HPPH, was able to be post-loaded at more than 90% efficiency across all types of nanoparticles (NPs). Moreover, the NPs have tunable release kinetics; ranging from 9% to 23% released by 96 hours in 1% serum albumin, depending on the surface modification used. Additionally, it was observed that the NPs had a photo-release mechanism where >60% of the payload was released when exposed to at least 2J of light. This held true with the photosensitizer and hydrophobic chemotherapeutics like Curcumin. To test the impact these modifications have in vitro, two different bladder cancer cell lines were chosen (UMUC3 and T24). These nanoparticles increase the efficacy of the photosensitizer by 4 fold in UMUC3, with cationic and the amino functionalized particles having the highest efficacy. This increase in efficacy, high uptake, and favorable sub-cellular localization makes the cationic modification of the nanoparticle extremely attractive for future studies.Keywords
Funding Information
- National Cancer Institute (CA 016156)
- Photolitec LLC.
This publication has 56 references indexed in Scilit:
- Multifunctional nanoplatforms for fluorescence imaging and photodynamic therapy developed by post-loading photosensitizer and fluorophore to polyacrylamide nanoparticlesNanomedicine: Nanotechnology, Biology and Medicine, 2012
- Multifunctional Biodegradable Polyacrylamide Nanocarriers for Cancer Theranostics—A “See and Treat” StrategyACS Nano, 2012
- Targeted Imaging and Therapy of Brain Cancer Using Theranostic NanoparticlesMolecular Pharmaceutics, 2010
- New Strategies for Fluorescent Probe Design in Medical Diagnostic ImagingChemical Reviews, 2009
- Conjugation of 2-(1′-Hexyloxyethyl)-2-devinylpyropheophorbide-a (HPPH) to Carbohydrates Changes its Subcellular Distribution and Enhances Photodynamic Activity in VivoJournal of Medicinal Chemistry, 2009
- Preliminary studies on LED-activated pyropheophorbide-α methyl ester killing cisplatin-resistant ovarian carcinoma cellsLaser Physics, 2009
- PEG Branched Polymer for Functionalization of Nanomaterials with Ultralong Blood CirculationJournal of the American Chemical Society, 2009
- Vascular Targeted Nanoparticles for Imaging and Treatment of Brain TumorsClinical Cancer Research, 2006
- Small-scale systems for in vivo drug deliveryNature Biotechnology, 2003
- Room‐temperature preparation and characterization of poly (ethylene glycol)‐coated silica nanoparticles for biomedical applicationsJournal of Biomedical Materials Research Part A, 2003